Protalix BioTherapeutics

PLX

NYSE MKT LLCHealth Care

Income Statement

Total Revenue$53.4M

Gross Profit$29.08M

Operating Income$3.92M

EBITDA$6.52M

EBIT$5.22M

Pre-tax Income$19.27M

Net Income$2.93M

Cash Equivalent$24.44M

Total Debt$15.93M

Book Value$33.5M

Book Value Per Share0.46

Return on Equity (ROE)+6.79%

Return on Assets (ROA)+3.99%

Return on Invested Capital (ROI)+6.79%

Net Profit Margin+5.49%

Current Ratio2.34

Quick Ratio1.50

Long-Term Debt / Equity6.61